Position in CRMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,066,061
+$295,458 QoQ
Shares Held
135,804
+117.1% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 194 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. CRMD ranks #58 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in CRMD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,066,061 | 135,804 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $770,603 | 62,549 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,425,836 | 231,467 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $642,240 | 79,289 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $394,829 | 48,865 | Shares | Sole | 2024-11-12 | |
| 2022-09-30 | $43,293 | 15,298 | Shares | Sole | 2022-11-10 | |
| 2021-06-30 | $146,186 | 21,310 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $194,881 | 26,229 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||